{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T14:12:52Z","timestamp":1775311972750,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014976","name":"Liverpool School of Tropical Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014976","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon: X"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.toxcx.2026.100243","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:14:23Z","timestamp":1770884063000},"page":"100243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["In vitro-in vivo discord: A preclinical study of AZD2716 and its racemate with comparison to varespladib for the development of snake venom sPLA2 inhibitors"],"prefix":"10.1016","volume":"29","author":[{"given":"James L.","family":"Hearth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulia","family":"Surovtseva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Karjala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas R.","family":"Casewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Giang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4480-9891","authenticated-orcid":false,"given":"Matthew R.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxcx.2026.100243_bib1","doi-asserted-by":"crossref","first-page":"12972","DOI":"10.1021\/acs.jpcb.1c07298","article-title":"Quantum biochemical investigation of Lys49-PLA2 from Bothrops moojeni","volume":"125","author":"Barbosa","year":"2021","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.toxcx.2026.100243_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4320175","article-title":"Developing small molecule therapeutics for the initial and adjunctive treatment of snakebite","volume":"2018","author":"Bulfone","year":"2018","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.toxcx.2026.100243_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/molecules26113113","article-title":"Enantioselectivity in drug pharmacokinetics and toxicity: pharmacological relevance and analytical methods","volume":"26","author":"Coelho","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.toxcx.2026.100243_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-015985","article-title":"Oral varespladib for the treatment of snakebite envenoming in India and the USA (BRAVO): a phase II randomised clinical trial","volume":"9","author":"Gerardo","year":"2024","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.toxcx.2026.100243_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/toxins15090557","article-title":"Oral and IV varespladib rescue experiments in juvenile pigs with weakness induced by Australian and papuan Oxyuranus scutellatus venoms","volume":"15","author":"Gilliam","year":"2023","journal-title":"Toxins"},{"key":"10.1016\/j.toxcx.2026.100243_bib6","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/acsmedchemlett.6b00188","article-title":"Discovery of AZD2716: a novel secreted phospholipase A2 (sPLA2) inhibitor for the treatment of coronary artery disease","volume":"7","author":"Giordanetto","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.toxcx.2026.100243_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.toxicon.2012.09.006","article-title":"Phospholipases A2: unveiling the secrets of a functionally versatile group of snake venom toxins","volume":"62","author":"Guti\u00e9rrez","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.toxcx.2026.100243_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/jt\/5464388","article-title":"Biochemical and biological profiles of Bangladeshi russell's viper snake venom and neutralizing efficacy by Indian VINS polyvalent antivenom","author":"Hasan","year":"2025","journal-title":"J. Toxicol."},{"key":"10.1016\/j.toxcx.2026.100243_bib9","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1021\/acsmedchemlett.7b00505","article-title":"Discovery of a series of indole-2-carboxamides as selective secreted phospholipase A2 type X (sPLA2-X) inhibitors","volume":"9","author":"Knerr","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.toxcx.2026.100243_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.toxicon.2018.03.004","article-title":"Pros and cons of different therapeutic antibody formats for recombinant antivenom development","volume":"146","author":"Laustsen","year":"2018","journal-title":"Toxicon"},{"issue":"9","key":"10.1016\/j.toxcx.2026.100243_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/toxins8090248","article-title":"Varespladib (LY315920) appears to be a potent, broad-spectrum, inhibitor of snake venom phospholipase A2 and a possible pre-referral treatment for envenomation","volume":"8","author":"Lewin","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.toxcx.2026.100243_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/toxins10100380","article-title":"Delayed oral LY333013 rescues mice from highly neurotoxic, lethal doses of papuan taipan (Oxyuranus scutellatus) venom","volume":"10","author":"Lewin","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.toxcx.2026.100243_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001018","article-title":"Snakebite mortality in India: a nationally representative mortality survey","volume":"5","author":"Mohapatra","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.toxcx.2026.100243_bib14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/jama.2013.282836","article-title":"Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial","volume":"311","author":"Nicholls","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.toxcx.2026.100243_bib15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/toxins13040290","article-title":"Short linear motifs characterizing snake venom and mammalian phospholipases A2","volume":"13","author":"Peggion","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.toxcx.2026.100243_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2021.129913","article-title":"The synthetic varespladib molecule is a multifunctional inhibitor for PLA2 and PLA2-like ophidic toxins","volume":"1865","author":"Salvador","year":"2021","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.toxcx.2026.100243_bib17","first-page":"1","article-title":"Inhibitors and activators for myotoxic phospholipase A2-like toxins from snake venoms: a structural overview","volume":"216","author":"Salvador","year":"2024","journal-title":"Biochimie"},{"key":"10.1016\/j.toxcx.2026.100243_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53755-5","article-title":"Structural basis for phospholipase A2-like toxin inhibition by the synthetic compound varespladib (LY315920)","volume":"9","author":"Salvador","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxcx.2026.100243_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biochi.2026.03.006","article-title":"Structural and pharmacological analysis of a PLA 2 -like toxin in complex with the sPLA 2 inhibitor AZD2716: comparisons to varespladib","author":"Salvador","year":"2026","journal-title":"Biochimie"},{"issue":"20","key":"10.1016\/j.toxcx.2026.100243_bib20","doi-asserted-by":"crossref","first-page":"17931","DOI":"10.1021\/acs.jmedchem.4c02052","article-title":"Dose-response curves and the determination of IC50 and EC50 values","volume":"67","author":"Srinivasan","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.toxcx.2026.100243_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2021.106289","article-title":"Varespladib (LY315920) rescued mice from fatal neurotoxicity caused by venoms of five major Asiatic kraits (Bungarus spp.)","volume":"227","author":"Tan","year":"2022","journal-title":"Acta Trop."},{"key":"10.1016\/j.toxcx.2026.100243_bib22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/toxins9090290","article-title":"A review and database of snake venom proteomes","volume":"9","author":"Tasoulis","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.toxcx.2026.100243_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007059","article-title":"Strategy for a globally coordinated response to a priority neglected tropical disease: snakebite envenoming (WHO roadmap)","volume":"13","author":"Williams","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.toxcx.2026.100243_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/toxins12060356","article-title":"PLA2 inhibitor varespladib as an alternative to antivenom treatment for bites from Nikolsky's viper (Vipera berus nikolskii)","volume":"12","author":"Zinenko","year":"2020","journal-title":"Toxins"}],"container-title":["Toxicon: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590171026000020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590171026000020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T13:17:45Z","timestamp":1775308665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590171026000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":24,"alternative-id":["S2590171026000020"],"URL":"https:\/\/doi.org\/10.1016\/j.toxcx.2026.100243","relation":{},"ISSN":["2590-1710"],"issn-type":[{"value":"2590-1710","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro-in vivo discord: A preclinical study of AZD2716 and its racemate with comparison to varespladib for the development of snake venom sPLA2 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Toxicon: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxcx.2026.100243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100243"}}